REGENXBIO (RGNX) 424B5 Prospectus supplement for primary offering

0001590877424B5EX-FILING FEESCommon Stock, par value $0.0001 per share00 0001590877 2024-12-09 2024-12-09 0001590877 1 2024-12-09 2024-12-09 iso4217:USD xbrli:pure

Exhibit 107

Calculation of Filing Fee Tables

424(b)(5)

(Form Type)

REGENXBIO Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward  Form Type

Carry Forward  File Number

Carry Forward  Initial Effective Date

Filing Fee Previously Paid In Connection  with Unsold  Securities to  be Carried Forward

Newly Registered Securities

Fees to be Paid

Equity

Common Stock, par value $0.0001  per share

Rule 457(o) and 457(r)  (1)

N/A

N/A

$150,000,000

0.00015310

$22,965.00

Fees Previously Paid

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Carry Forward Securities

Carry Forward Securities

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Total Offering Amounts

$150,000,000

$22,965.00

Total Fees Previously Paid

N/A

Total Fee Offsets

N/A

Net Fee Due

$22,965.00

(1) The filing fee is calculated and is being paid pursuant to Rules 456(o) and 457(r) under the Securities Act of 1933, as amended (the “Securities Act”), based on the proposed maximum aggregate offering price. The registrant initially deferred payment of the registration fees for its Registration Statement on Form S-3 (File No. 333-269086) filed by the Registrant with the Securities and Exchange Commission on December 30, 2022 pursuant to Rules 456(b) and 457(r) under the Securities Act.